According to Inogen's latest financial reports the company's current revenue (TTM) is $0.31 B. In 2022 the company made a revenue of $0.37 B an increase over the years 2021 revenue that were of $0.35 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.31 B | -16.32% |
2022 | $0.37 B | 5.37% |
2021 | $0.35 B | 16.05% |
2020 | $0.30 B | -14.77% |
2019 | $0.36 B | 1.07% |
2018 | $0.35 B | 43.57% |
2017 | $0.24 B | 22.98% |
2016 | $0.20 B | 27.56% |
2015 | $0.15 B | 41.29% |
2014 | $0.11 B | 49.17% |
2013 | $75.44 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ResMed RMD | $4.50 B | 1,326.88% | ๐บ๐ธ USA |
Masimo MASI | $2.04 B | 548.83% | ๐บ๐ธ USA |
Chart Industries GTLS | $3.35 B | 964.09% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | $27.04 M | -91.43% | ๐บ๐ธ USA |
Philips PHG | $19.72 B | 6,147.91% | ๐ณ๐ฑ Netherlands |